Maravai LifeSciences Holdings Inc MRVI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
26.16UNCH (UNCH)
Volume
18,000
Close
26.16quote price arrow down-0.72 (-2.68%)
Volume
1,446,979
52 week range
23.05 - 63.55
Loading...
  • Open26.97
  • Day High27.35
  • Day Low26.00
  • Prev Close26.88
  • 52 Week High63.55
  • 52 Week High Date08/23/21
  • 52 Week Low23.05
  • 52 Week Low Date07/15/22

Key Stats

  • Market Cap6.676B
  • Shares Out255.21M
  • 10 Day Average Volume1.63M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-37.57

KEY STATS

  • Open26.97
  • Day High27.35
  • Day Low26.00
  • Prev Close26.88
  • 52 Week High63.55
  • 52 Week High Date08/23/21
  • 52 Week Low23.05
  • 52 Week Low Date07/15/22
  • Market Cap6.676B
  • Shares Out255.21M
  • 10 Day Average Volume1.63M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-37.57

RATIOS/PROFITABILITY

  • EPS (TTM)1.91
  • P/E (TTM)13.72
  • Fwd P/E (NTM)17.89
  • EBITDA (TTM)664.779M
  • ROE (TTM)91.14%
  • Revenue (TTM)920.28M
  • Gross Margin (TTM)83.68%
  • Net Margin (TTM)61.14%
  • Debt To Equity (MRQ)138.52%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Maravai LifeSciences Holdings Inc

There is no recent news for this security.

Profile

MORE
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine...
Carl Hull
Chairman of the Board, Chief Executive Officer
Kevin Herde
Chief Financial Officer
Peter Leddy Ph.D.
Executive Vice President, Chief Administrative Officer
Kurt Oreshack
General Counsel, Secretary
Address
10770 Wateridge Circle Suite 200
Suite 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
EXEL
Exelixis Inc
21.55+0.03+0.14%
HALO
Halozyme Therapeutics Inc
45.04-0.09-0.20%
NVCR
Novocure Ltd
77.64+2.02+2.67%
NTRA
Natera Inc
52.16+0.69+1.34%
SRPT
Sarepta Therapeutics Inc
111.47+5.45+5.14%